Alendronate sodium and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alendronate sodium (alendronate sodium) and Vancomycin (vancomycin). Common drug interactions include fall among females and eosinophilic pneumonia acute among males.

The phase IV clinical study analyzes what interactions people have when they take Alendronate sodium and Vancomycin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.



On Jul, 10, 2026

38 people who take Alendronate sodium and Vancomycin together, and have interactions are studied.

Alendronate sodium and Vancomycin drug interactions.

What are the common drug interactions of Alendronate Sodium and Vancomycin, by gender? *:

female:

  1. Fall
  2. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  3. Arthralgia (joint pain)
  4. Back pain
  5. Infection
  6. Influenza like illness
  7. Kidney infection
  8. Pain in extremity
  9. Peripheral swelling
  10. Mouth ulceration (mouth ulcers)

male:

  1. Eosinophilic pneumonia acute (eosinophil accumulates in the lung-acute)
  2. Chronic kidney disease
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Renal failure (kidney dysfunction)

What are the common drug interactions of Alendronate Sodium and Vancomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pneumonia
  2. Pulmonary alveolar haemorrhage (acute bleeding)
  3. Pulmonary hypertension (increase in blood pressure in the lung artery)

40-49:

  1. Asthenia (weakness)
  2. Back disorder
  3. Back pain
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cervical vertebral fracture
  6. Confusional state
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Cough
  9. Decreased appetite
  10. Diarrhoea

50-59:

  1. Influenza
  2. Infusion related reaction
  3. Joint swelling
  4. Laryngeal disorder (disease of larynx related to voice)
  5. Lethargy (tiredness)
  6. Limb discomfort (discomfort in leg)
  7. Lower respiratory tract infection
  8. Morton's neuralgia (severe pain on the ball of the foot and at the base of toe)
  9. Muscular weakness (muscle weakness)
  10. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)

60+:

  1. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  2. Urinary tract infection
  3. Infection
  4. Influenza like illness
  5. Kidney infection
  6. Mouth ulceration (mouth ulcers)
  7. Pain in extremity
  8. Peripheral swelling
  9. Upper limb fracture
  10. Blood urine present

What are the existing conditions these people have? *

  1. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 13 people, 34.21%
  2. Immunodeficiency Common Variable: 10 people, 26.32%
  3. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 9 people, 23.68%
  4. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 18.42%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.89%
  6. Cardiac Failure: 3 people, 7.89%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.89%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 7.89%
  9. Skin Infection: 2 people, 5.26%
  10. Asthma: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Alendronate sodium and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alendronate sodium and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alendronate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on alendronate sodium and vancomycin (the active ingredients of Alendronate sodium and Vancomycin, respectively), and Alendronate sodium and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: